Genetic mechanisms involved in the phenotype of down syndrome

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 13, Issue 3, 2007, Pages 199-206

  Patterson, David ^a,b  

^a UNIVERSITY OF DENVER   (United States)

^b UNIVERSITY OF DENVER   (United States)

Author keywords

Down syndrome; Gene regulation; Genome structure and function; Genotype phenotype correlations

Indexed keywords

CELL PROTEIN; DNA; INTERACTOME; METABOLOME; MICRORNA; PHENOME; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHROMOSOME 21; CHROMOSOME STRUCTURE; DNA METHYLATION; DNA SEQUENCE; DOWN SYNDROME; GENE; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOME ANALYSIS; HSA21 GENE; HUMAN; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA EDITING; TRISOMY;

CHROMOSOMES, HUMAN, PAIR 21; DNA METHYLATION; DOWN SYNDROME; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; PHENOTYPE; TRISOMY;

EID: 35348987032     PISSN: 10804013     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/mrdd.20162     Document Type: Review

References (84)

1. Aapola U, Kawasaki K, Scott HS, et al. 2000. Isolation and initial characterization of a novel zinc finger gene. DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. Genomics 65:293-298.
2. Antonarakis SE, Epstein CJ. 2006. The challenge of Down syndrome. Trends Mol Med 12:473-479.
3. Antonarakis SE, Lyle R, Dermitzakis ET, et al. 2004. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5:725-738.
4. Arron JR, Winslow MM, Polleri A, et al. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600.
5. Austin CP, Battey JF, Bradley A, et al. 2004. The Knockout Mouse Project. Nat Genet 36:921-924.
6. Bagley PJ, Selhub J. 2000. Analysis of folate form distribution by affinity followed by reversed-phase chromatography with electrochemical detection. Clin Chem 46:404-411.
7. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
8. Bartel DP, Chen C-Z. 2004. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5:396-400.
9. Brodsky G, Barnes T, Bleskan J, et al. 1997. The human GARS-AIRS-GART gene encodes two proteins which are differentially expressed during human brain development and temporally overexpressed in cerebellum of individuals with Down syndrome. Hum Mol Genet 6:2043-2050.
10. Butler C, Bowersox J, Forbes S, et al. 2006. The production of transgenic mice expressing human cystathionine β-synthase to study Down syndrome. Behav Genet 36:429-438.
11. Cabrejo L, Guyant-Marechal L, Laquerriere A, et al. 2006. Phenotype associated with APP duplication in five families. Brain 129:2966-2976.
12. Centers for Disease Control and Prevention. 2006. Improved national prevalence estimates for 18 selected major birth defects - United States, 1999-2001. Morb Mortal Wkly 54:1301-1305.
13. Cornish-Bowden A, Cardenas ML. 2000. From genome to cellular phenotype - a role for metabolic flux analysis? Nat Biotechnol 16:267-268.
14. Crawley JN. 2007. What's wrong with my mouse? Hoboken, NJ: Wiley.
15. Cui Q, Yu Z, Pan Y, et al. 2007. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun 352:733-738.
16. Dermitzakis ET, Kirkness E, Schwarz S, et al. 2004. Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. Genome Res 14:852-859.
17. Dermitzakis ET, Reymond A, Antonarakis SE. 2005. Conserved non-genic sequences - an unexpected feature of mammalian genomes. Nat Rev Genet 6:151-157.
18. Deutsch S, Lyle R, Dermitzakis ET, et al. 2005. Gene expression variation and expression quantitative trait mapping of human chromosome 21 genes. Hum Mol Genet 14:3741-3749.
19. ENCODE Project Consortium. 2004. The ENCODE (ENCyclopedia of DNA Elements) Project. Science 306:636-640.
20. Fahr KK-L, Grimson A, Jan C, et al. 2005. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310:1817-1821.
21. Gaidatzis D, van Nimwegen E, Hausser J, et al. 2007. Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinform 8:69.
22. Gardiner K. 2006. Transcriptional dysregulation in Down syndrome: predictions for altered protein complex stoichiometrics and post-translational modification, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behav Genet 36:439-453.
23. Gardiner K, Costa ACS. 2006. The proteins of chromosome 21. Am J Med Genet C 142:196-205.
24. Giardine B, Riemer C, Hefferon T, et al. 2007. PhenCode: connecting ENCODE data with mutations and phenotype. Hum Mutat 28:554-562.
25. Gitton Y, Dahmane N, Baik S, et al. 2002. A gene expression map of human chromosome 21 orthologues in the mouse. Nature 420:586-590.
26. Hata K, Kusumi M, Yokomine T, et al. 2006. Meiotic and epigenetic aberrations in the Dnmt3l-deficient male germ cells. Mol Reprod Dev 73:116-122.
27. Hattori M, Fujiyama A, Taylor TD, et al. 2000. The DNA sequence of human chromosome 21. Nature 405:311-319.
28. Head E, Lott IT, Patterson D, et al. 2007. Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology. Targets for nonpharmacological intervention. J Alzhheimer's Dis 11:61-76.
29. Hegele RA. 2007. Copy-number variations add a new layer of complexity in the human genome. CMAJ 176:441-442.
30. Hu Y-H, Warnatz H-J, Vanhecke D, et al. 2006. Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins. BMC Genomics 7:155.
31. Iafrate AJ, Feuk L, Rivera MN, et al. 2004. Detection of large-scale variation in the human genome. Nat Genet 36:949-951.
32. Kaddurah-Daouk R, Beecher C, Kristal BS, et al. 2004. Bioanalytical advances for metabolomics and metabolic profiling. PharmaGenomics 4:46-52.
33. Kahlem P. 2006. Gene-dosage effect on chromosome 21 transcriptome in Trisomy 21: implication in Down syndrome cognitive disorders. Behav Genet 36:416-428.
34. Kawahara Y, Zinshteyn B, Sethupathy P, et al. 2007. Redirection of silencing targets by adenosine-to-inosine editing of mRNAs. Science 315:1137-1140.
35. Kim Y. 2005. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr 135:2703-2709.
36. Korenberg JR, Kawashima H, Pulst SM, et al. 1990. Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am J Hum Genet 47:236-246.
37. Kosik KS, Krichevsky AM. 2005. The elegance of the microRNAs: a neuronal perspective. Neuron 47:779-782.
38. Lage K, Karlberg EO, Sterling ZM, et al. 2007. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 25:309-316.
39. Li CM, Guo M, Salas M, et al. 2006. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 7:24.
40. Li Z, Yu T, Monshima M, et al. 2007. Duplication of the entire 22.9-Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16:1359-1366.
41. Liu M, Ge Y, Cabelof DC, et al. 2005. Structure and regulation of the murine reduced folate carrier gene. J Biol Chem 280:5588-5597.
42. Liu M, Ge Y, Payton SG, et al. 2006. Transcriptional regulation of the human reduced folate carrier in childhood aculte lymphoblastic leukemia cells. Clin Cancer Res 12:608-616.
43. Lujambio A, Ropero S, Ballestar E, et al. 2007. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 67:1424-1429.
44. Maas S, Kawahara Y, Tamburro K, et al. 2006. A-to-I RNA editing and human disease. RNA Biol 3:1-9.
45. Mao R, Zielke CL, Zielke HR, et al. 2003. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81:457-467.
46. Miller CA, Sweatt JD. 2007. Covalent modification of DNA regulates memory formation. Neuron 53:857-869.
47. Moscow JA, Gong M, He R, et al. 1995. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 55:3790-3794.
48. Muntean AG, Ge Y, Tauw JW, et al. 2006. Transcription factor GATA-1 and Down syndrome leukemogenesis. Leuk Lymphoma 47:986-997.
49. Nam J-W, Shin K-R, Han J, et al. 2005. Human microRNA prediction through a probabilistic co-learning model of sequence and structure. Nucleic Acids Res 33:3570-3581.
50. Niwa R, Slack FJ. 2007. The evolution of animal microRNA function. Curr Opin Genet Dev 17:1-6.
51. Nord AS, Chang PJ, Conklin BR, et al. 2006. The international gene trap consortium website: a portal to all publicly available gene trap cel lines in mouse. Nucleic Acids Res 34:D642-D648.
52. O'Doherty A, Ruf S, Mulligan C, et al. 2005. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309:2033-2037.
53. O'Leary DA, Pritchard MA, Xu D, et al. 2004. Tissue-specific overexpression of the HSA21 gene GABPA: implications for DS. Biochim Biophys Acta 1739:81-87.
54. Olson LE, Richtsmeier JT, Leszl J, et al. 2004a. A chromosome 21 "critical region" does not cause specific Down syndrome phenotypes. Science 306:687-690.
55. Olson LE, Roper RJ, Baxter LL, et al. 2004b. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev Dyn 230:581-589.
56. Olson LE, Roper RJ, Sengstaken CL, et al. 2007. Trisomy for the Down syndrome critical region is necessary but not sufficient for brain phenotypes of trisomic mice. Hum Mol Genet 16:774-782.
57. Pant SS, Moser HW, Krane SM. 1968. Hyperuricemia in Down's syndrome. J Clin Endocrinol Metab 28:472-478.
58. Patja K, Pukkala E, Sund R, et al. 2006. Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer 118:1769-1772.
59. Patterson D, Costa ACS. 2005. Down syndrome and genetics - a case of linked histories. Nat Rev Genet 6:137-147.
60. Payton SG, Haska CL, Flatley RM, et al. 2007. Effects of 5′ untranslated region diversity on the posttranscriptional regulation of the human reduced folate carrier. Biochim Biophys Acta 1769:131-138.
61. Payton SG, Whetstine JR, Ge Y, et al. 2005. Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and C/EBP β and identification of a downstream repressor. Biochim Biophys Acta 1727:45-57.
62. Pokharel S, Beal PA. 2006. High-throughput screening for functional adenosine to inosine RNA editing systems. ACS Chem Biol 1:761-765.
63. Rachidi M, Lopes C, Charron G, et al. 2005. Spatial and temporal localization during embryonic and fetal human development of the transcription factor SIM2 in brain regions altered in Down syndrome. Int J Dev Neurosci 23:475-484.
64. Reymond A, Marigo V, Yaylaoglu MB, et al. 2002. Human chromosome 21 gene expression atlas in the mouse. Nature 420:582-586.
65. Ronan A, Fagan K, Christie L, et al. 2007. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J Med Genet 44:448-451.
66. Roper RJ, Reeves RH. 2006. Understanding the basis for Down syndrome phenotypes. PloS Genet 2:0231-0236.
67. Rovelet-Lecrux A, Hannequin D, Raux G, et al. 2006. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 38:24-26.
68. Rozen S, Cudkowicz ME, Bogdanov M, et al. 2005. Metabolomic analysis and signatures in motor neuron disease. Metabolomics 1:101-108.
69. Salehi A, Delcroix J-D, Belichenko PV, et al. 2006. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic degeneration. Neuron 51:1-14.
70. Schumacher A, Kapranov P, Kaminsky Z, et al. 2006. Microarray based DNA methylation profiling: technology and applications. Nucleic Acids Res 34:528-542.
71. Sebat J, Lakshmi B, Troge J, et al. 2004. Large-scale copy number polymorphism in the human genome. Science 305:525-528.
72. Shames DS, Minna JD, Gazdar AF. 2007. DNA methylation in health, disease, and cancer. Curr Mol Med 7:85-102.
73. Shapiro BL. 1983. Down syndrome - a disruption of homeostasis. Am J Med Genet 14:241-269.
74. Song F, Smith JF, Kimura MT, et al. 2005. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. Proc Natl Acad Sci USA 102:3336-3341.
75. Spiegel EK. 2007. Psychomotor deficits in mice transgenic for a mutant adenylosuccinate lyase associated with autism in humans, Ph.D. thesis, University of Colorado at Denver and Health Sciences Center, Colorado.
76. Stranger BE, Forrest MS, Clark AG, et al. 2005. Genome-wide associations of gene expression variation in humans. PLoS Genet 1:695-704.
77. Stranger BE, Forrest MS, Dunning M, et al. 2007. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848-853.
78. Thomas DJ, Rosenbloom KR, Clawson H, et al. 2006. The ENCODE Project at UC Santa Cruz. Nucleic Acids Res 35:D663-D667.
79. Turek-Plewa J, Jagodzinski PP. 2005. The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 10:631-647.
80. Vyas P, Crispino JD. 2007. Molecular insights into Down syndrome-associated leukemia. Curr Opin Pediatr 19:9-14.
81. Watanabe H, Fujiyama A, Hattori M, et al. 2004. DNA sequence and comparative analysis of chimpanzee chromosome 22. Nature 249:382-388.
82. Whetstine JR, Flatley RM, Matherly LH. 2002. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J 367:629-640.
83. Whetstine JR, Matherly LH. 2001. The basal promoters of the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. J Biol Chem 276:6350-6358.
84. Yamada Y, Watanabe H, Miura F, et al. 2004. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. Genome Res 14:247-266.